Pulse Biosciences, Inc. (NASDAQ:PLSE)
| Market Cap | $3.35B+248.0% |
| Revenue (ttm) | $1.49M+1637.2% |
| Net Income | -$83.72M-12.0% |
| EPS | -$1.20-4.3% |
| Shares Out | 73.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 466,798 |
| Open | $44.84 |
| Previous Close | $44.41 |
| Day's Range | $44.62 - $46.03 |
| 52-Week Range | $12.95 - $58.94 |
| Beta | 1.64 |
| Analysts | Buy |
| Price Target | $63.40(+39.19%) |
| Earnings Date | Feb 18, 2027 |
About PLSE
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Pulse Biosciences, Inc. Stock Analysis — InsiderScore
Pulse Biosciences, Inc. scored higher than 55% of companies evaluated by InsiderBuying, and ranked 24th out of 50 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Pulse Biosciences, Inc. bought $199.9K of stock across 4 purchases in the last 90 days, the largest of them $50.0K.
The average purchase added about 59% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
3 firms rating PLSE in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 18, 2027Earnings report
$PLSE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in PLSE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PLSE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PLSE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PLSE Revenue by Segment or Geography
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PLSE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PLSE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PLSE
| VTIVanguard Morningstar Total Stock Market ETF | $28.43M |
| IWMiShares Russell 2000 ETF | $22.06M |
| VXFVanguard Extended Market ETF | $11.87M |
| IWOiShares Russell 2000 Growth ETF | $7.98M |
| VTWOVanguard Russell 2000 ETF | $5.80M |
| SCHASchwab U.S. Small-Cap ETF | $4.62M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from PLSE’s recent data — informational, not investment advice
What’s Behind the Score
News check: Rating upgrade to Buy, positive study enrollment progress, and favorable analyst positioning outweigh valuation concerns from one headline.
Recent Insider Activity
Insider Score Trend Over Time
-11.2 since Sep 24Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.44% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 1.21% |
| PCSG | Polen 5Perspectives Small-Mid Growth ETF | 0.92% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.40% |
| IWC | iShares Micro-Cap ETF | 0.26% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.26% |
| ESSC | Eventide Small Cap ETF | 0.24% |
| ISMD | Inspire Small/Mid Cap ETF | 0.23% |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.18% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.14% |
| IHI | iShares U.S. Medical Devices ETF | 0.14% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.08% |
Weight is the stock’s share of each fund’s holdings.
